Literature DB >> 11182666

Medial rectus resection(s) with adjustable suture for intermittent exotropia of the convergence insufficiency type.

D G Choi1, A L Rosenbaum.   

Abstract

BACKGROUND: The surgical results for intermittent exotropia of the convergence insufficiency type have been reported to be of varying success. The purpose of this study is to evaluate the surgical results of medial rectus muscle (MR) resection(s) with adjustable suture for this condition.
METHODS: Twenty-one consecutive patients with intermittent exotropia of the convergence insufficiency type were included in this retrospective study. All patients had a history of prolonged difficulties at near work unrelieved by nonsurgical treatment. Unilateral or bilateral MR resection(s) were done with the adjustable suture, which was tied at the first postoperative day. The target angle was an esotropia of 10 to 20 PD at distance and an esotropia of 5 to 10 PD at near. Postoperatively Fresnel prisms were used temporarily in patients manifesting a consecutive esotropia with diplopia at distance. Postoperative follow-up period was between 6 months and 24 months with a mean of 9.1 months.
RESULTS: MR resection(s) with the adjustable suture reduced the mean exodeviation at near from 25.7 to 3 PD. It also reduced the exodeviation at distance from 11.4 to -2 PD (esodeviation). The mean near-distance difference was collapsed from 14.3 PD preoperatively to 5 PD postoperatively.
CONCLUSIONS: MR resection(s) with adjustable suture combined with intentional postoperative aggressive overcorrection and the use of Fresnel prisms is useful in intermittent exotropia of the convergence insufficiency type. The intentional overcorrection during the immediate postoperative period at distance and near is required to prevent long-term undercorrection.

Entities:  

Mesh:

Year:  2001        PMID: 11182666     DOI: 10.1067/mpa.2001.111137

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  9 in total

1.  Surgical outcomes of three different surgical techniques for treatment of convergence insufficiency intermittent exotropia.

Authors:  M F Farid; E A Abdelbaset
Journal:  Eye (Lond)       Date:  2017-12-22       Impact factor: 3.775

2.  Sustained improvement of reading symptoms following botulinum toxin A injection for convergence insufficiency.

Authors:  Jon Peiter Saunte; Jonathan M Holmes
Journal:  Strabismus       Date:  2014-04-30

3.  Surgical outcomes of unilateral lateral rectus recession versus recess-resect in children with convergence insufficiency type intermittent exotropia.

Authors:  Yoon Kyung Jang; Seok Hyun Bae; Dong Gyu Choi
Journal:  Sci Rep       Date:  2022-05-21       Impact factor: 4.996

4.  Strabismus surgery for internuclear ophthalmoplegia with exotropia in multiple sclerosis.

Authors:  Wendy E Adams; Jacqueline A Leavitt; Jonathan M Holmes
Journal:  J AAPOS       Date:  2008-12-12       Impact factor: 1.220

5.  Early results of slanted recession of the lateral rectus muscle for intermittent exotropia with convergence insufficiency.

Authors:  Bo Young Chun; Kyung Min Kang
Journal:  J Ophthalmol       Date:  2015-01-26       Impact factor: 1.909

6.  Slanted bilateral lateral rectus recession for convergence insufficiency-type intermittent exotropia: a retrospective study.

Authors:  Meiyu Ren; Qi Wang; Lihua Wang
Journal:  BMC Ophthalmol       Date:  2020-07-14       Impact factor: 2.209

7.  Evaluation of single-stage adjustable strabismus surgery under conscious sedation.

Authors:  Pradeep Sharma; Anurag Julka; Ritu Gadia; Anjolie Chhabra; Maya Dehran
Journal:  Indian J Ophthalmol       Date:  2009 Mar-Apr       Impact factor: 1.848

8.  Long-term Results of Slanted Recession of Bilateral Lateral Rectus Muscle for Intermittent Exotropia with Convergence Insufficiency.

Authors:  Ji Min Kwon; Soo Jung Lee
Journal:  Korean J Ophthalmol       Date:  2019-08

9.  Slanted recession on bilateral lateral rectus for the treatment of intermittent Exotropia with convergence insufficiency.

Authors:  Yueping Li; Huiyu Lin
Journal:  BMC Ophthalmol       Date:  2022-03-24       Impact factor: 2.209

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.